NS
CNTA

NBC Securities’s Centessa Pharmaceuticals CNTA Stock Holding History

NBC Securities’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60
Closed -$2.38K – 2446
2026
Q1 		$2.38K Hold
60
– – ﹤0.01% 2289
2025
Q4 		$1.5K Sell
60
-78
-57% -$1.98K ﹤0.01% 2466
2025
Q3 		$3.35K Hold
138
– – ﹤0.01% 2304
2025
Q2 		$1K Hold
138
– – ﹤0.01% 2363
2025
Q1 		$1K Buy
+138
New +$2.26K ﹤0.01% 2071
2024
Q4 		– Sell
-138
Closed -$2K – 1412
2024
Q3 		$2K Hold
138
– – ﹤0.01% 2006
2024
Q2 		$1K Hold
138
– – ﹤0.01% 2029
2024
Q1 		$1K Hold
138
– – ﹤0.01% 2051
2023
Q4 		$1K Hold
138
– – ﹤0.01% 2053
2023
Q3 		$0 Buy
+138
New +$944 ﹤0.01% 2119

NBC Securities's CNTA Position: Q2 2026 in Review

NBC Securities sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 60 shares — an estimated $2.38K sold.

NBC Securities first reported a position in CNTA in Q3 2023 and held it in 10 quarters. The position peaked at $3.35K in Q3 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • NBC Securities reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • NBC Securities sold 60 Centessa Pharmaceuticals shares in Q2 2026, an estimated $2.38K.
  • NBC Securities first reported a position in Centessa Pharmaceuticals in Q3 2023 and held it in 10 quarters.
  • NBC Securities's Centessa Pharmaceuticals position peaked at $3.35K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.